Related Experiment Video
Updated: Jun 3, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2
Ka To Shum1, Eric Lik Hang Lui, Sybil Cheuk Ki Wong
1Department of Biochemistry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
Abstract:
Inorganic polyphosphate (polyP) plays a number of critical roles in bacterial persistence, stress, and virulence. PolyP intracellular metabolism is regulated by the polyphosphate kinase (PPK) protein families, and inhibition of PPK activity is a potential approach to disrupting polyP-dependent processes in pathogenic organisms. Here, we biochemically characterized Mycobacterium tuberculosis (MTB) PPK2 and developed DNA-based aptamers that inhibit the enzyme's catalytic activities. MTB PPK2 catalyzed polyP-dependent phosphorylation of ADP to ATP at a rate 838 times higher than the rate of polyP synthesis. Gel filtration chromatography suggested MTB PPK2 to be an octamer. DNA aptamers were isolated against MTB PPK2. Circular dichroism revealed that aptamers grouped into two distinct classes of secondary structure; G-quadruplex and non-G-quadruplex. A selected G-quadruplex aptamer was highly selective for binding to MTB PPK2 with a dissociation constant of 870 nM as determined by isothermal titration calorimetry. The binding between MTB PPK2 and the aptamer was exothermic yet primarily driven by entropy. This G-quadruplex aptamer inhibited MTB PPK2 with an IC(50) of 40 nM and exhibited noncompetitive inhibition kinetics. Mutational mechanistic analysis revealed an aptamer G-quadruplex motif is critical for enzyme inhibition. The aptamer was also tested against Vibrio cholerae PPK2, where it showed an IC(50) of 105 nM and insignificant inhibition against more distantly related Laribacter hongkongensis PPK2.
Insights
Researchers developed DNA aptamers to inhibit Mycobacterium tuberculosis PPK2, a key enzyme in bacterial survival. A G-quadruplex aptamer showed potent and selective inhibition, offering a potential therapeutic strategy against tuberculosis.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Inorganic polyphosphate (polyP) is crucial for bacterial persistence, stress response, and virulence.
- Polyphosphate kinase (PPK) enzymes regulate intracellular polyP metabolism.
- Inhibiting PPK offers a strategy to disrupt polyP-dependent processes in pathogens.
Purpose of the Study:
- Biochemically characterize Mycobacterium tuberculosis (MTB) PPK2.
- Develop DNA aptamers to inhibit MTB PPK2 activity.
- Investigate the inhibitory mechanism and specificity of aptamers.
Main Methods:
- Biochemical assays to determine enzyme kinetics and catalytic rates.
- Gel filtration chromatography for protein complex analysis.
- Isothermal titration calorimetry for binding affinity and thermodynamics.
- Circular dichroism for aptamer secondary structure determination.
- Enzyme inhibition assays (IC50 determination) and kinetic analysis.
- Mutational analysis to identify critical aptamer motifs.
Main Results:
- MTB PPK2 exhibits a high polyP-dependent phosphorylation rate.
- MTB PPK2 exists as an octamer.
- A G-quadruplex DNA aptamer selectively binds MTB PPK2 with high affinity (Kd = 870 nM).
- The aptamer noncompetitively inhibits MTB PPK2 with an IC50 of 40 nM.
- The G-quadruplex motif is essential for inhibition.
- The aptamer shows cross-inhibition against Vibrio cholerae PPK2.
Conclusions:
- DNA aptamers, particularly G-quadruplex structures, are effective inhibitors of MTB PPK2.
- The developed aptamer demonstrates high selectivity and potency.
- This aptamer represents a promising lead for developing novel anti-tubercular therapeutics targeting PPK2.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Enzyme Inhibition
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Viral Protein Synthesis
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Inhibitors of Bacterial DNA Synthesis

